Question:
Does CMS require that the JW modifier be reported when billing for packaged drugs?
Answer:
Currently, CMS is not requiring the JW modifier when billing for packaged drugs, so the provider must consider using the same billing practice as with payable drugs or only report one charge line that reports the billing units associated only with the amount of drug administered.